Pinsent Masons advises Yule Catto on the sale of Uquifa

01 Dec 2011 | 10:49 am | 1 min. read

International law firm Pinsent Masons has advised Yule Catto & Co plc, international producer of speciality chemicals, on the sale of its pharmaceuticals business, Uquifa to the listed Indian chemicals manufacturer Vivimed Labs for £35m.

Uquifa, which operates through Spanish and Mexican subsidiaries, is an established manufacturer of active pharmaceutical ingredients. The company has manufacturing sites in Spain and Mexico employing a total of 390 people. 

Adrian Whitfield, Chief Executive of Yule Catto said: "I am delighted to be able to announce this disposal.  Following the PolymerLatex acquisition we completed earlier this year, this marks the final step in a long process of transforming Yule Catto into a substantial highly focussed Specialty Polymer business.  We are pleased we have been able to find a good home for our Pharma business and wish the new owners and our former employees every success." 

The Pinsent Masons team advising on the sale was led by Martin Shaw, Head of Corporate, Europe, and Shiv Sibal, Senior Associate, supported by Emma Metcalfe (corporate), Michael Hunter and Jon Robinson (tax).  The team also worked closely with Yule Catto's Spanish advisers, Garrigues, and their Mexican advisers, Baker & McKenzie. Vivimed were advised by Dickinson Dees. 

Shiv Sibal, Corporate Senior Associate at Pinsent Masons LLP, commented: "The sale of Uquifa represents an important development for Yule Catto and will allow them to continue to focus on the growth of their Polymers division following their transformational acquisition of PolymerLatex earlier this year.  Having worked closely with them on the PolymerLatex acquisition, we are delighted to have supported Yule Catto again in achieving one of its strategic objectives."

Latest press releases

Show me all press releases

Pinsent Masons hires senior litigation and investigations partner Melanie Ryan in London

Multinational law firm Pinsent Masons has appointed litigation partner Melanie Ryan to join its Global Investigations team in London.

Pinsent Masons MPillay advises SUSI Partners on investment in Alba Renewables

Law firm Pinsent Masons MPillay has advised Swiss-based infrastructure investment manager SUSI Partners on its investment in Alba Renewables to build a renewable energy infrastructure business focused on The Philippines.

Pinsent Masons advises La Bottega on Australian acquisition

Multinational law firm Pinsent Masons has advised Italian producer of hotel essentials La Bottega on its acquisition of a majority stake in Australian company Vanity Group.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons MPillay advises SUSI Partners on investment in Alba Renewables

Law firm Pinsent Masons MPillay has advised Swiss-based infrastructure investment manager SUSI Partners on its investment in Alba Renewables to build a renewable energy infrastructure business focused on The Philippines.

Pinsent Masons advises Bestinver Infra, FCR on acquisition of remaining shares in Irish toll road concession & operation companies

Pinsent Masons has advised Bestinver Infra, FCR on the acquisition of the remaining shares in N6 (Concession) Holdings Limited and N6 (Operations) Ltd, with Japanese co-investor Daiwa Energy & Infrastructure Co. Ltd.

Pinsent Masons advises Sandoz on acquisition of remaining shares in Rowex Joint Venture

Multinational law firm Pinsent Masons has advised Sandoz on the acquisition of the remaining shares in Rowex Limited, a joint venture in Ireland between Sandoz and Rowa Pharmaceuticals.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.